Wondaleaf at UNFPA Conference
Nov. 2016. Wondaleaf was showcased to UNFPA officials in a conference at United Nation in Bangkok. The pivotal meeting also led to Wondaleaf’s clinical trial in South Africa in 2017. The functional performance study conducted by MatCH has now been completed. The favourable results will be published in due course.
Ministry of Science, Technology and Innovation Grant
June 2017. In addition to the grants from PlatCOM Venture Sdn Bhd of Agensi Innovasi Malaysia (RM 700,000) and Cradle Fund Sdn Bhd of Ministry of Finance (RM 500,000), Twin Catalyst Sdn Bhd is honored to receive about RM 1,800,000 grant from Ministry of Science, Technology and Innovation for continuing the work on Wondaleaf. The […]
Wondaleaf Clinical Trials
Wondaleaf is currently undergoing clinical trials with the aim of establishing its efficacy as a barrier contraceptive, and its utility in menstrual control. These trials further have the aim of establishing the acceptability and usability of this device, and will be used in the Malaysian Device Authority, US Food and Drug Agency, Australian Therapeutic Goods Administration and […]
Twin Catalyst at Innovation Malaysia Conference
Wondaleaf was featured at IMC in 2015. The event was organised by PLATCOM VENTURES, a federal government innovation agency which funded Wondaleaf project.
Signing of MOU with University College of Technology Sarawak
On the 5th of February, 2015, the founder of Twin Catalyst and inventor of Wondaleaf, Dr. John Tang Ing Ching signed a Memorandum of Understanding (MOU) with the University College of Technology Sarawak (UCTS). The signing of the MOU signified Twin Catalyst’s first big step forward of many towards a closer partnership with local resources […]